Carlos Pulido, MD
Anesthesiology · Athens, GANPI 1598730848
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Medtronic at 24.1% of the total. Reporting peaked in 2024 at $879 and has fallen 77.1% since, to $201 in 2025. Among anesthesiology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 104 payments — averaging $27.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$684
- Stimwave Technologies Incorporated$284
- Vertiflex, Inc.$264
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$256
- Amgen$192
- Stryker$150
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,79098%
- Education$522%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 15 | $684 |
| Stimwave Technologies Incorporated | 7 | $284 |
| Vertiflex, Inc. | 4 | $264 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 25 | $256 |
| Amgen(2 entities) | 6 | $192 |
| Stryker | 1 | $150 |
| Scilex Pharmaceuticals Inc. | 6 | $130 |
| Nalu Medical, Inc. | 2 | $125 |
| Neurelis, Inc. | 1 | $119 |
| Boston Scientific | 4 | $98 |
| Collegium Pharmaceutical, Inc. | 6 | $95 |
| Foundation Fusion Solutions, LLC | 5 | $94 |
| Abbott | 4 | $69 |
| Teva Pharmaceuticals USA, Inc. | 4 | $62 |
| Forte Bio-pharma LLC | 2 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Curonix LLC | 2 | $30 |
| Nevro Corp. | 1 | $16 |
| AbbVie | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Assertio Therapeutics, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
| Kaleo, Inc. | 1 | $12 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$233
- INTELLIS ADAPTIVESTIM$176
- mild Device Kit$150
- AIMOVIG$121
- VALTOCO$119
- StimQ Receiver Stimulator Kit Channel A US w Receiver$104
- StimQ Freedom 4A Receiver Kit Channel A US Receiver$104
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$104
- Freedom 4A Receiver Kit Channel A US w Receiver$104
- Freedom 8A Receiver Kit Channel A US w Receiver$104
How this compares
$2,842 in reported general payments places this provider in the 95th percentile of 1,137 anesthesiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 60 | $149,262 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,649 | $101,787 |
| BelbucaBuprenorphine Hcl | 127 | $93,573 |
| Buprenorphine | 269 | $69,616 |
| Xtampza ErOxycodone Myristate | 140 | $51,493 |
| ZtlidoLidocaine | 62 | $41,576 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,316 | $28,747 |
| Nucynta ErTapentadol Hcl | 15 | $10,659 |
| OxycontinOxycodone Hcl | 20 | $10,136 |
| Oxycodone Hcl | 578 | $9,145 |
| Pregabalin | 549 | $7,359 |
| Tramadol Hcl ErTramadol Hcl | 123 | $5,930 |
| MovantikNaloxegol Oxalate | 13 | $5,200 |
| Lidocaine | 47 | $3,748 |
| Gabapentin | 389 | $3,676 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta Er | $95 | $155,725282 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $256 | $149,26260 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $130 | $41,57662 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,137 anesthesiology providers in Georgia.
Other anesthesiology in Athens
- Margaret HoltzMarietta$622K
- Mark HamiltonAtlanta$351K
- Michael AshmoreAtlanta$214K
- Jessica McCabeJohns Creek$62K
- Stephen KushinsLawrenceville$62K
- Uma ShastriAtlanta$35K
- Jessica McCounRome$34K
- Amit PatelLawrenceville$17K
- Melat GebreAtlanta$16K
- Laura DowneyAtlanta$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.